FDA Releases Guidance Document for Human Plasma-Derived Biological Products and Animal Plasma or Serum-Derived Products

Summary

The Food and Drug Administration (FDA) has made available a guidance document to help companies prepare their submissions for biologics license applications (BLAs) for human plasma-derived biological products, animal plasma or serum-derived products, aiming to reduce unnecessary burdens while maintaining public health protection.